US$ 20.45
pharmaceutical companies manufacturing glp-1 receptor agonist medications Market Overview: Agonists and the Obesity Market | Blog Harnessing GLP-1 Receptor Agonists for
Description
Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets

A.MarmorS.HovertsenS.GronskiJ.et al (2021)

J Pharm Technol

DOI: 10.2147/DMSO.S494919, Rigamonti, A

NASH caused hepatomegaly, fibrosis, and inflammation in all mice, with aged mice showing increased heart weight, left ventricular volumes, and subtle systolic and diastolic dysfunction, thus NASH tends to worsen age-related cardiac dysfunction [37]
